TACT — TransAct Technologies Income Statement
0.000.00%
Last trade - 00:00
- $44.59m
- $35.71m
- $72.63m
- 84
- 53
- 31
- 56
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.7 | 30.6 | 39.4 | 58.1 | 72.6 |
Cost of Revenue | |||||
Gross Profit | 21.9 | 12.9 | 15.4 | 24.4 | 38.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 45.4 | 38.8 | 46.6 | 65.8 | 66.9 |
Operating Profit | 0.343 | -8.17 | -7.2 | -7.68 | 5.71 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.367 | -8.17 | -6.08 | -7.9 | 5.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.516 | -5.63 | -4.04 | -5.94 | 4.75 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.516 | -5.63 | -4.04 | -5.94 | 4.75 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0.516 | -5.63 | -4.04 | -5.94 | 4.75 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.067 | -0.719 | -0.587 | -0.599 | 0.474 |
Dividends per Share |